Bruker Corporation - Common Stock (NQ:BRKR)

34.46 +0.72 (+2.13%)

Streaming Delayed Price Updated: 2:46 PM EDT, Mar 18, 2026 Add to My Watchlist

Price and Volume

Volume	1,175,034
Open	33.60
Bid (Size)	34.45 (100)
Ask (Size)	34.49 (100)
Prev. Close	33.74
Today's Range	33.21 - 34.63
52wk Range	28.53 - 56.22
Shares Outstanding	146,727,377
Dividend Yield	0.58%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers

March 04, 2026

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

Via StockStory

Performance

YTD	-28.4%	-28.4%
1 Month	-9.6%	-9.6%
3 Month	-23.4%	-23.4%
6 Month	+3.6%	+3.6%
1 Year	-26.6%	-26.6%

More News

Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings?

February 26, 2026

Via StockStory

Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

February 25, 2026

From Bruker Corporation

Via Business Wire

Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications

February 24, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

February 23, 2026

From Bruker Corporation

Via Business Wire

Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology

February 23, 2026

From Bruker Corporation

Via Business Wire

The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call

February 19, 2026

Via StockStory

1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 That Underwhelm

February 17, 2026

Via StockStory

3 Profitable Stocks We Keep Off Our Radar

February 12, 2026

Via StockStory

Why Bruker (BRKR) Stock Is Trading Lower Today

February 12, 2026

Via StockStory

Bruker (BRKR) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

Via The Motley Fool

Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates

February 12, 2026

Via StockStory

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

From Bruker Corporation

Via Business Wire

Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

February 09, 2026

From Bruker Corporation

Via Business Wire

Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

February 09, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Quarterly Preferred Stock Dividend

February 05, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

February 05, 2026

From Bruker Corporation

Via Business Wire

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

January 15, 2026

Via StockStory

Why Bruker (BRKR) Shares Are Plunging Today

January 13, 2026

Via StockStory

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

January 09, 2026

From Bruker Corporation

Via Business Wire

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

January 08, 2026

From Bruker Corporation

Via Business Wire

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

January 07, 2026

From Bruker Corporation

Via Business Wire

3 Unpopular Stocks We Think Twice About

January 06, 2026

Via StockStory

Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks

January 05, 2026

Via StockStory

Frequently Asked Questions

Is Bruker Corporation - Common Stock publicly traded?

Yes, Bruker Corporation - Common Stock is publicly traded.

What exchange does Bruker Corporation - Common Stock trade on?

Bruker Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Bruker Corporation - Common Stock?

The ticker symbol for Bruker Corporation - Common Stock is BRKR on the Nasdaq Stock Market

What is the current price of Bruker Corporation - Common Stock?

The current price of Bruker Corporation - Common Stock is 34.46

When was Bruker Corporation - Common Stock last traded?

The last trade of Bruker Corporation - Common Stock was at 03/18/26 02:46 PM ET

What is the market capitalization of Bruker Corporation - Common Stock?

The market capitalization of Bruker Corporation - Common Stock is 5.06B

How many shares of Bruker Corporation - Common Stock are outstanding?

Bruker Corporation - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.